toxikon ceo | Labcorp to Acquire Toxikon

Keyword	CPC	PCC	Volume	Score	Length of keyword
toxikon ceo	0.66	1	343	95	11
toxikon	0.28	0.5	2884	48	7
ceo	1.83	0.7	8323	8	3

Keyword	CPC	PCC	Volume	Score
toxikon corporation	1.35	0.8	4511	31
toxikon consortium	0.91	0.4	2136	72
toxikon corporation bedford ma	0.47	0.8	3530	44

Search Results related to toxikon ceo on Search Engine

Labcorp to Acquire Toxikon | citybiz
citybiz.co

https://www.citybiz.co/article/177820/labcorp-to-acquire-toxikon/

DA: 8 PA: 92 MOZ Rank: 89

Labcorp Completes Acquisition of Toxikon Corporation
businesswire.com

https://www.businesswire.com/news/home/20211203005484/en/Labcorp-Completes-Acquisition-of-Toxikon-Corporation

DA: 74 PA: 38 MOZ Rank: 77

Labcorp Completes Acquisition of Toxikon Corporation
labcorp.com

https://www.labcorp.com/newsroom/labcorp-completes-acquisition-toxikon-corporation

WEBBURLINGTON, N.C., Dec. 3, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services. The …

DA: 50 PA: 72 MOZ Rank: 100

Labcorp to Acquire Toxikon, Expanding Nonclinical …
labcorp.com

https://ir.labcorp.com/news-releases/news-release-details/labcorp-acquire-toxikon-expanding-nonclinical-development

WEBNov 18, 2021 · “Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” …

DA: 95 PA: 86 MOZ Rank: 50

Labcorp to Acquire Toxikon, Expanding Nonclinical …
businesswire.com

https://www.businesswire.com/news/home/20211118005744/en/Labcorp-to-Acquire-Toxikon-Expanding-Nonclinical-Development-Testing-Capabilities-for-Pharmaceutical-Biotech-and-Medical-Device-Clients

WEBNov 18, 2021 · “Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of...

DA: 52 PA: 10 MOZ Rank: 43

Labcorp Completes Acquisition of Toxikon Corporation
businesswire.com

https://www.businesswire.com/news/home/20211203005484/en/Labcorp-Completes-Acquisition-of-Toxikon-Corporation

WEBDec 3, 2021 · Media: Christopher Allman-Bradshaw – 336-436-8263. [email protected]. Investors: Chas Cook – 336-436-5076. [email protected]. Labcorp (NYSE: LH), a …

DA: 6 PA: 94 MOZ Rank: 1

Labcorp to acquire life science firm with $40M in annual revenues
wraltechwire.com

https://wraltechwire.com/2021/11/18/labcorp-to-acquire-life-science-firm-with-40m-in-annual-revenues/

WEBNov 18, 2021 · “Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” …

DA: 18 PA: 84 MOZ Rank: 10

Lax Desai - President & CEO - Toxikon Corporation
linkedin.com

https://www.linkedin.com/in/lax-desai-38046015b

WEBJun 2000 - Present 23 years 9 months. View Lax Desai’s profile on LinkedIn, the world’s largest professional community. Lax has 1 job listed on their profile. See the complete … Title: President & CEO at Toxikon … Location: 30 followers Connections: 25

Title: President & CEO at Toxikon …
Location: 30 followers
Connections: 25

DA: 67 PA: 93 MOZ Rank: 18

Labcorp to Acquire Toxikon | citybiz
citybiz.co

https://www.citybiz.co/article/177820/labcorp-to-acquire-toxikon/

WEBNovember 18, 2021. BURLINGTON, N.C.– ( BUSINESS WIRE )– Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a …

DA: 92 PA: 81 MOZ Rank: 22

Labcorp to Acquire Toxikon, Expanding Nonclinical …
labcorp.com

https://www.labcorp.com/newsroom/labcorp-acquire-toxikon-expanding-nonclinical-development-testing-capabilities-pharmaceutical

WEBNov 18, 2021 · “As a part of the Labcorp family, we will have an opportunity to broaden our impact through access to extensive resources, knowledge and support,” said Dr. …

DA: 8 PA: 23 MOZ Rank: 13